Fact CheckerSign in

NCT06485700Recruiting

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

Peer-based medication delivery decreases the cost of transportation and the opportunity cost of travel while HIT can support peer activities by facilitating targeted adherence counseling, teleconsultation, synchronization of clinical care, and pharmacy activities. The investigators have implemented a pilot program of door-to-door peer-based medication delivery and HIT in western Kenya, and preliminary data indicate improved adherence and blood pressure. However, the effectiveness of this implementation strategy is not fully established. Therefore, the objective of the study is to use the PRECEDE-PROCEED framework to conduct transdisciplinary implementation research to test the hypothesis that integrating peer delivery of medications with HIT (PT4A) improves medication adherence and reduces blood pressure among patients with uncontrolled hypertension in western Kenya.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1140 (estimated)
First submitted
27 Jun 2024
Start date
18 Nov 2025
Primary completion date
31 Mar 2028
Lead sponsor
NYU Langone Health
NCT number
NCT06485700

What you commit to

  • Study type: Interventional
  • Planned participants: 1140
  • From 18 Nov 2025 to the primary completion date, 31 Mar 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • terminal illness, and

Other

  • hypertensive emergency requiring immediate medical attention,
  • inability to provide informed consent.

Who the study is looking for

  • Adult participants enrolled in AMPATH's CDM Program with uncontrolled hypertension (SBP ≥ 140 or diastolic BP (DBP) ≥ 90)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
EldoretKenyaRecruiting
-
Coordinator of this site? Confirm its status
KitaleKenyaRecruiting
-
Coordinator of this site? Confirm its status
WebuyeKenyaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.